Diagnostic Medical Systems SA Cash Flow Conversion Efficiency

Latest as of December 2025: -0.001x

Diagnostic Medical Systems SA cash flow conversion efficiency. Based on the latest financial reports, Diagnostic Medical Systems SA (ALDMS) has a cash flow conversion efficiency ratio of -0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-25.00K ≈ $-29.23K USD) by net assets (€20.66 Million ≈ $24.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Diagnostic Medical Systems SA (2009–2025)

Cash flow conversion efficiency of Diagnostic Medical Systems SA from 2009 to 2025. This chart illustrates how Diagnostic Medical Systems SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Diagnostic Medical Systems SA for real-time trading data and today's change.

Diagnostic Medical Systems SA Cash Flow Conversion Ratio Explained

Diagnostic Medical Systems SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Diagnostic Medical Systems SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnostic Medical Systems SA ranked by their cash flow conversion efficiency. Also see Diagnostic Medical Systems SA (ALDMS) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
UTI Inc
KQ:179900
-0.224x
PolTREG S.A.
WAR:PTG
-0.154x
Sunrise New Energy Co. Ltd
NASDAQ:EPOW
-0.678x
Kein Hing International Bhd
KLSE:7199
0.008x
Sierra Nevada Gold Inc
AU:SNX
-0.044x
ENVIONEER Co.Ltd
KQ:317870
0.015x
Naos Small Cap Opportunities Company Ltd
AU:NSC
0.063x
Ozderici Gayrimenkul Yatirim Ortakligi AS
IS:OZGYO
0.006x

Annual Cash Flow Conversion Efficiency for Diagnostic Medical Systems SA (2009–2025)

The table below shows the annual cash flow conversion efficiency of Diagnostic Medical Systems SA from 2009 to 2025. Review ALDMS FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €20.66 Million
≈ $24.16 Million
€-254.00K
≈ $-296.95K
-0.012x -104.83%
2024-12-31 €14.16 Million
≈ $16.56 Million
€3.60 Million
≈ $4.21 Million
0.254x +312.12%
2023-12-31 €13.72 Million
≈ $16.04 Million
€-1.65 Million
≈ $-1.92 Million
-0.120x -326.87%
2022-12-31 €18.17 Million
≈ $21.24 Million
€960.00K
≈ $1.12 Million
0.053x +199.71%
2021-12-31 €20.44 Million
≈ $23.89 Million
€-1.08 Million
≈ $-1.27 Million
-0.053x +75.51%
2020-12-31 €17.05 Million
≈ $19.93 Million
€-3.69 Million
≈ $-4.31 Million
-0.216x -982.13%
2019-12-31 €14.84 Million
≈ $17.35 Million
€364.00K
≈ $425.55K
0.025x +160.07%
2018-12-31 €17.88 Million
≈ $20.90 Million
€-730.00K
≈ $-853.45K
-0.041x +73.21%
2017-12-31 €23.35 Million
≈ $27.30 Million
€-3.56 Million
≈ $-4.16 Million
-0.152x -437.35%
2016-12-31 €28.27 Million
≈ $33.05 Million
€-802.00K
≈ $-937.62K
-0.028x +83.21%
2015-12-31 €25.27 Million
≈ $29.55 Million
€-4.27 Million
≈ $-4.99 Million
-0.169x -101.25%
2014-12-31 €22.01 Million
≈ $25.73 Million
€-1.85 Million
≈ $-2.16 Million
-0.084x -336.16%
2013-12-31 €13.47 Million
≈ $15.75 Million
€479.00K
≈ $560.00K
0.036x +136.56%
2012-12-31 €13.98 Million
≈ $16.35 Million
€-1.36 Million
≈ $-1.59 Million
-0.097x +76.67%
2011-12-31 €8.90 Million
≈ $10.41 Million
€-3.71 Million
≈ $-4.34 Million
-0.417x -322.48%
2010-12-31 €11.17 Million
≈ $13.05 Million
€-1.10 Million
≈ $-1.29 Million
-0.099x +67.09%
2009-12-31 €11.78 Million
≈ $13.78 Million
€-3.53 Million
≈ $-4.13 Million
-0.300x --

About Diagnostic Medical Systems SA

PA:ALDMS France Medical Devices
Market Cap
$27.58 Million
€23.59 Million EUR
Market Cap Rank
#23880 Global
#378 in France
Share Price
€0.91
Change (1 day)
+0.22%
52-Week Range
€0.87 - €1.47
All Time High
€2.70
About

Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.